## Clinical Scenario Analysis This patient presents with **malignant hypertension with acute kidney injury**, characterized by: - Severely elevated BP (210/130 mmHg) - Acute rise in creatinine (0.9 → 3.2 mg/dL) - RBC casts and proteinuria (acute glomerulonephritis picture) - **Markedly elevated renin** (8.5 ng/mL/hr; normal 0.5–1.6) - **Elevated aldosterone** (35 ng/dL; normal 4–31) - **Elevated renin + elevated aldosterone** = **secondary hyperaldosteronism** ## Pathophysiology of Secondary Hyperaldosteronism in Malignant Hypertension ### Two-Hit Mechanism **Key Point:** In malignant hypertension, the **juxtaglomerular apparatus (JGA)** senses two stimuli simultaneously: 1. **Decreased renal perfusion pressure** (paradoxically, despite systemic hypertension) - Malignant hypertension causes acute arteriolar necrosis and fibrinoid necrosis of afferent arterioles - This reduces glomerular capillary pressure and filtration - The JGA interprets this as "hypotension" and releases renin 2. **Increased sympathetic nervous system activation** - Acute kidney injury and volume depletion activate baroreceptors - Increased renal sympathetic nerve activity → β₁-adrenergic stimulation of juxtaglomerular cells - Direct β₁-mediated renin release ### RAAS Cascade Activation ```mermaid flowchart TD A[Malignant Hypertension]:::outcome --> B[Acute arteriolar necrosis]:::outcome B --> C[Decreased glomerular perfusion]:::outcome A --> D[Sympathetic activation]:::outcome C --> E[JGA senses 'hypotension']:::decision D --> F[β1-adrenergic stimulation of JG cells]:::decision E --> G[Renin release ↑]:::action F --> G G --> H[Angiotensin II formation ↑]:::outcome H --> I[Aldosterone secretion ↑]:::action H --> J[Vasoconstriction ↑]:::action I --> K[Na+ and H2O retention]:::outcome J --> L[Further BP elevation]:::urgent K --> L ``` **High-Yield:** This is **secondary hyperaldosteronism** because the elevated renin is the PRIMARY driver. The adrenal gland is responding appropriately to angiotensin II; it is not autonomously secreting aldosterone. ### Distinguishing Primary vs. Secondary Hyperaldosteronism | Feature | Primary (Conn) | Secondary (Malignant HTN) | |---------|---|---| | **Renin** | ↓ Suppressed | ↑ Elevated | | **Aldosterone** | ↑ Elevated | ↑ Elevated | | **Renin:Aldo ratio** | <1 | >1 | | **Cause of HTN** | Adrenal adenoma/hyperplasia | Kidney disease, malignant HTN | | **Mechanism** | Autonomous aldo production | Appropriate RAAS activation | **Clinical Pearl:** The **elevated renin in the setting of hypertension** is the key finding that distinguishes this as secondary hyperaldosteronism. In primary HA, renin is suppressed because the high aldosterone feeds back negatively on the JGA. ## Why Acute Kidney Injury Develops 1. Malignant hypertension → arteriolar necrosis (acute tubular necrosis of afferent arterioles) 2. Reduced GFR → acute kidney injury 3. RAAS activation → further vasoconstriction → worsening renal perfusion (vicious cycle) 4. Proteinuria and RBC casts → acute glomerulonephritis picture **Mnemonic:** **RAAS in Renal Crisis** = **R**enin ↑, **A**ldosterone ↑, **A**ngiotensin II ↑, **S**ympathetic ↑ → vicious cycle of hypertension and renal failure. [cite:Harrison 21e Ch 297; Robbins 10e Ch 20]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.